// App-Quantinova.ai

P879 : EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA

Researchers

Presenter

  • Stefanie Huhn

Principal Investigators

  • Alexandra M. Poos

  • Elias K. Mai

  • Mathias Hnel

  • Hans J. Salwender

  • Jan Drig

  • Igor Wolfgang Blau

  • Christoph Scheid

  • Katja C Weisel

  • Markus Munder

  • Oscar Berlanga

  • Uta Bertsch

  • Hartmut Goldschmidt

  • Niels Weinhold

Medical Centers

  • The Binding Site Group, Ltd,Birmingham,Royaume-uni

  • Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany

  • Medical Clinic,Charité University Medicine Berlin,Berlin,Alemania

  • Medical Clinic,Charité University Medicine Berlin,Berlin,Alemania

  • Medical Clinic,Charité University Medicine Berlin,Berlin,Alemania

  • Department of Internal M

  • The Binding Site Group, Ltd,Birmingham,Reino Unido

  • Asklepios Tumorze

  • The Binding Site Group, Ltd,Birmingham,Reino Unido

  • Department of Hematology and Stem Cell Transplantation,University of Duisburg-Essen,Essen,Germany

  • Third Department of Medicine,University Medicine Mainz of Johannes Gutenberg ,Mainz,Germany

  • Department of Hematology and Stem Cell Transplantation,University of Duisburg-Essen,Essen,Germany

  • Department of Hematology and Stem Cell Transplantation,University of Duisburg-Essen,Essen,Germany

  • The Binding Site Group, Ltd,Birmingham,Vereinigtes Königreich

  • Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

  • Department of Internal Medicine I, University Hospital Cologne, Cologne,

  • Third Department of Medicine,University Medicine Mainz of Johannes Gutenberg ,Mainz,Germany

  • Oncology, Hematology and BMT,University Medical-Center Hamburg-Eppendorf,Hamburg,Germany

  • The Binding Site Group, Ltd,Birmingham,Vereinigtes Königreich

  • Department of Internal Medicine III,Clinic Chemnitz,Chemnitz,Alemania

  • Department of Internal Medicine,Heidelberg University Hospital,He

  • Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

  • Department of Oncology, Hematology and BMT,University Medical Center Hamburg-Eppendo

  • The Binding Site Grou

  • Department of Internal Medicine III,Clinic Chem

  • Department of Internal Medicine I, University Hospital Cologne, Cologne,

  • Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany

  • Department of Internal Medicine III,Clinic Chemnitz,Chemnitz,Alemania

  • Department of Internal Medicine III,Clinic Chemnitz,Chemnitz,Alemania

  • Medical Clinic,Charité University Medicine Berlin,Berlin,Alemania

  • Department of Internal Medicine I ,University of Cologne,Cologne,Deutschland

  • Department of Internal Medicine II, Klinikum Chemnitz gGmbH, Chemnitz, Germany

  • Oncology, Hematology and BMT,University Medical-Center Hamburg-Eppendorf,Hamburg,Germany

  • Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

  • Dept. of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany,

  • Department of Internal Medicine II, Klinikum Chemnitz gGmbH, Chemnitz, Germany

  • Third Department of Medicine,University Medicine Mainz of Johannes Gutenberg ,Mainz,Germany

  • Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

  • Third Department of Medicine,University Medicine Mainz of Johannes Gutenberg ,Mainz,Germany

  • Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany

  • Department of Hematology and Stem Cell Transplantation,University of Duisburg-Essen,Essen,Germany

  • Departme

  • Medical Clinic,Charité University Medicine Berlin,Berlin,Alemania

  • Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany

  • The Binding Site, Birmingham, United Kingdom

  • Department of Internal Medicine I, University Hospital Cologne, Cologne,

  • Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany

  • Medical Clinic,Charité University Medicine Berlin,Berlin,Alemania

  • Department of Internal Medicine I ,University of Cologne,Cologne,Deutschland

  • Third Department of Medic

Locations

  • South Africa

  • Germany

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Immunoglobulin A

  • Fibrillin-1

Drug/Treatment

  • Lenalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved